PARIS--(BUSINESS WIRE)--Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on discovering and developing innovative gene therapies ...
We report a case of posterior lens nucleus displacement following an intravitreal injection of bevacizumab (IVB). To the best of our knowledge this complication has not been previously reported. A ...
On the other hand, Dr. William Barlow of the University of Utah's Moran Eye Center notes, "Dilation isn't always required. In fact, if you are seeing your eye doctor solely to get a prescription, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results